Genetic Susceptibility to Renal Cell Carcinoma

Baylor College of Medicine1 site in 1 country6 target enrollmentJuly 2008

ConditionsRenal Cell Carcinoma

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Renal Cell Carcinoma
Sponsor: Baylor College of Medicine
Enrollment: 6
Locations: 1
Primary Endpoint: To identify interindividual differences in inherited genetic instability
Status: Terminated
Last Updated: 6 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will further the understanding of the genetic events leading to the development of RCC.

Detailed Description

This study will further the understanding of the genetic events leading to the development of RCC; explore the genetic basis for genetic instability and how it affects cancer risk; and eventually provide a means of identifying a subgroup of individuals who are most likely to develop RCC. Such individuals may then be targeted for intervention programs such as chemoprevention or dietary modification.

Registry

clinicaltrials.gov

Start Date

July 2008

End Date

March 2013

Last Updated

6 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Baylor College of Medicine

Responsible Party

Principal Investigator

Seth Lerner

Professor

Baylor College of Medicine

Eligibility Criteria

Inclusion Criteria

•Adult patients of any ethnicity or sex, who have a been diagnosed with possible Renal Cell Carcinoma within the past year.

Exclusion Criteria

•Must not have received chemotherapy, biological therapy or radiation therapy in the 6 months preceding enrollment will
•Must not have had RCC, or metastatic RCC,
•Must not have had a renal transplantation